Association of neighbourhood migrant density and risk of non-affective psychosis: a national, longitudinal cohort study.


Journal

The lancet. Psychiatry
ISSN: 2215-0374
Titre abrégé: Lancet Psychiatry
Pays: England
ID NLM: 101638123

Informations de publication

Date de publication:
04 2020
Historique:
received: 03 12 2019
revised: 22 01 2020
accepted: 05 02 2020
pubmed: 9 3 2020
medline: 1 4 2020
entrez: 9 3 2020
Statut: ppublish

Résumé

Elevated risk of psychotic disorders in migrant groups is a public mental health priority. We investigated whether living in areas of high own-region migrant density was associated with reduced risk of psychotic disorders among migrants and their children, and whether generation status, probable visible minority status, or region-of-origin affected this relationship. We used the Swedish registers to identify migrants and their children born between Jan 1, 1982, and Dec 31, 1996, and living in Sweden on or after their 15th birthday. We tracked all included participants from age 15 years or date of migration until emigration, death, or study end (Dec 31, 2016). The outcome was an ICD-10 diagnosis of non-affective psychosis (F20-29). We calculated own-region and generation-specific own-region density within the 9208 small areas for market statistics neighbourhoods in Sweden, and estimated the relationship between density and diagnosis of non-affective psychotic disorders using multilevel Cox proportional hazards models, adjusting for individual confounders (generation status, age, sex, calendar year, lone dwelling, and time since migration [migrants only]), family confounders (family income, family unemployment, and social welfare), and neighbourhood confounders (deprivation index, population density, and proportion of lone dwellings), and using the Akaike information criterion (AIC) to compare model fit. Of 468 223 individuals included in the final cohort, 4582 (1·0%) had non-affective psychotic disorder. Lower own-region migrant density was associated with increased risk of psychotic disorders among migrants (hazard ratio [HR] 1·05, 95% CI 1·02-1·07 per 5% decrease) and children of migrants (1·03, 1·01-1·06), after adjustment. These effects were stronger for probable visible minority migrants (1·07, 1·04-1·11), including migrants from Asia (1·42, 1·15-1·76) and sub-Saharan Africa (1·28, 1·15-1·44), but not migrants from probable non-visible minority backgrounds (0·99, 0·94-1·04). Among migrants, adding generation status to the measure of own-region density provided a better fit to the data than overall own-region migrant density (AIC 36 103 vs 36 106, respectively), with a 5% decrease in generation-specific migrant density corresponding to a HR of 1·07 (1·04-1·11). Migrant density was associated with non-affective psychosis risk in migrants and their children. Stronger protective effects of migrant density were found for probable visible minority migrants and migrants from Asia and sub-Saharan Africa. For migrants, this risk intersected with generation status. Together, these results suggest that this health inequality is socially constructed. Wellcome Trust, Royal Society, Mental Health Research UK, University College London, National Institute for Health Research, Swedish Research Council, and FORTE.

Sections du résumé

BACKGROUND
Elevated risk of psychotic disorders in migrant groups is a public mental health priority. We investigated whether living in areas of high own-region migrant density was associated with reduced risk of psychotic disorders among migrants and their children, and whether generation status, probable visible minority status, or region-of-origin affected this relationship.
METHODS
We used the Swedish registers to identify migrants and their children born between Jan 1, 1982, and Dec 31, 1996, and living in Sweden on or after their 15th birthday. We tracked all included participants from age 15 years or date of migration until emigration, death, or study end (Dec 31, 2016). The outcome was an ICD-10 diagnosis of non-affective psychosis (F20-29). We calculated own-region and generation-specific own-region density within the 9208 small areas for market statistics neighbourhoods in Sweden, and estimated the relationship between density and diagnosis of non-affective psychotic disorders using multilevel Cox proportional hazards models, adjusting for individual confounders (generation status, age, sex, calendar year, lone dwelling, and time since migration [migrants only]), family confounders (family income, family unemployment, and social welfare), and neighbourhood confounders (deprivation index, population density, and proportion of lone dwellings), and using the Akaike information criterion (AIC) to compare model fit.
FINDINGS
Of 468 223 individuals included in the final cohort, 4582 (1·0%) had non-affective psychotic disorder. Lower own-region migrant density was associated with increased risk of psychotic disorders among migrants (hazard ratio [HR] 1·05, 95% CI 1·02-1·07 per 5% decrease) and children of migrants (1·03, 1·01-1·06), after adjustment. These effects were stronger for probable visible minority migrants (1·07, 1·04-1·11), including migrants from Asia (1·42, 1·15-1·76) and sub-Saharan Africa (1·28, 1·15-1·44), but not migrants from probable non-visible minority backgrounds (0·99, 0·94-1·04). Among migrants, adding generation status to the measure of own-region density provided a better fit to the data than overall own-region migrant density (AIC 36 103 vs 36 106, respectively), with a 5% decrease in generation-specific migrant density corresponding to a HR of 1·07 (1·04-1·11).
INTERPRETATION
Migrant density was associated with non-affective psychosis risk in migrants and their children. Stronger protective effects of migrant density were found for probable visible minority migrants and migrants from Asia and sub-Saharan Africa. For migrants, this risk intersected with generation status. Together, these results suggest that this health inequality is socially constructed.
FUNDING
Wellcome Trust, Royal Society, Mental Health Research UK, University College London, National Institute for Health Research, Swedish Research Council, and FORTE.

Identifiants

pubmed: 32145763
pii: S2215-0366(20)30059-6
doi: 10.1016/S2215-0366(20)30059-6
pmc: PMC7083220
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

327-336

Subventions

Organisme : Wellcome Trust
ID : 101272/Z/13/Z
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Références

BMJ. 2016 Mar 15;352:i1030
pubmed: 26979256
Schizophr Res. 2017 Dec;190:82-87
pubmed: 28318842
J Urban Health. 2016 Dec;93(6):1027-1045
pubmed: 27718048
Am J Psychiatry. 2005 Jan;162(1):12-24
pubmed: 15625195
Am J Public Health. 2012 Dec;102(12):e33-66
pubmed: 23078507
Soc Psychiatry Psychiatr Epidemiol. 2002 Nov;37(11):527-31
pubmed: 12395142
Am Sociol Rev. 2012 Jun 1;77(3):354-379
pubmed: 24648570
Health Place. 2009 Sep;15(3):670-8
pubmed: 19117792
Schizophr Res. 2019 Jun;208:268-275
pubmed: 30738697
Lakartidningen. 2020 Jan 13;117:
pubmed: 31935043
BMJ Open. 2013 Jun 28;3(6):
pubmed: 23811171
Schizophr Res. 2018 May;195:501-505
pubmed: 28969931
Can J Psychiatry. 2006 Mar;51(4):205-9
pubmed: 16629344
Schizophr Res. 2006 Oct;87(1-3):205-11
pubmed: 16905294
Psychol Med. 2019 Oct;49(14):2354-2363
pubmed: 30514409
Am J Psychiatry. 2008 Jan;165(1):66-73
pubmed: 18086750
Psychol Med. 2018 Sep;48(12):1985-1992
pubmed: 29328019
Women Birth. 2016 Apr;29(2):168-71
pubmed: 26520636
Psychol Med. 2008 Aug;38(8):1083-94
pubmed: 17988420
CMAJ. 2015 Jun 16;187(9):637-638
pubmed: 25964389
Psychol Med. 2007 Oct;37(10):1413-25
pubmed: 17472758
Int J Epidemiol. 2007 Aug;36(4):761-8
pubmed: 17517810
Psychiatr Serv. 2016 Mar;67(3):265-74
pubmed: 26695493
Health Place. 2014 Nov;30:177-86
pubmed: 25305475
J Epidemiol Community Health. 2004 Dec;58(12):1017-8
pubmed: 15547063
JAMA Psychiatry. 2018 Nov 1;75(11):1128-1136
pubmed: 30140915
Am J Psychiatry. 2012 Oct;169(10):1117-8
pubmed: 23032390
Curr Opin Psychiatry. 2013 Mar;26(2):166-71
pubmed: 23286992
Soc Psychiatry Psychiatr Epidemiol. 2014 Jul;49(7):1093-102
pubmed: 24554124
BMJ. 2010 Oct 21;341:c5367
pubmed: 20966012
Am J Psychiatry. 2015 Aug 1;172(8):784-92
pubmed: 25815418
Psychol Med. 2011 Jun;41(6):1263-9
pubmed: 20860862
Public Health Rep. 2001 Sep-Oct;116(5):404-16
pubmed: 12042604
Psychol Med. 2011 May;41(5):897-910
pubmed: 20663257
Schizophr Bull. 2016 Nov;42(6):1363-1371
pubmed: 27038469
Springerplus. 2013 May 14;2(1):222
pubmed: 23853744
BMJ. 2001 Dec 8;323(7325):1336-8
pubmed: 11739218
Epidemiol Rev. 2008;30:84-100
pubmed: 18669521
Schizophr Bull. 2016 May;42(3):712-22
pubmed: 26834027
Int J Soc Psychiatry. 2000 Spring;46(1):34-46
pubmed: 14529077
Front Hum Neurosci. 2014 Mar 27;8:179
pubmed: 24734016
Br J Psychiatry. 2012 Oct;201(4):282-90
pubmed: 22844021
Int J Health Geogr. 2016 Jul 01;15(1):21
pubmed: 27368370
Ann Epidemiol. 2005 Jan;15(1):71-9
pubmed: 15571996
Int J Epidemiol. 2007 Aug;36(4):751-8
pubmed: 17440031
Ethn Health. 2008 Sep;13(4):321-34
pubmed: 18701992
World Psychiatry. 2019 Oct;18(3):247-258
pubmed: 31496097
Br J Psychiatry. 2012 Jul;201(1):11-9
pubmed: 22753852
Soc Sci Med. 2012 Dec;75(12):2107-15
pubmed: 22591822
BMC Womens Health. 2017 Sep 5;17(1):72
pubmed: 28870195

Auteurs

Jennifer Dykxhoorn (J)

Division of Psychiatry, University College London, London, UK; Department of Primary Care and Population Health, University College London, London, UK. Electronic address: j.dykxhoorn@ucl.ac.uk.

Glyn Lewis (G)

Division of Psychiatry, University College London, London, UK.

Anna-Clara Hollander (AC)

Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.

James B Kirkbride (JB)

Division of Psychiatry, University College London, London, UK.

Christina Dalman (C)

Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH